Clinical Trials
4 trialsNCT07623577 2026-06-03
Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases
Fudan University
Phase 2 Recruiting
NCT01083966 2026-06-01
Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
Northwell Health
Phase 1 Suspended
NCT05271240 2026-06-01
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Northwell Health
Phase 3 Recruiting
NCT02971501 2026-05-29
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
National Cancer Institute (NCI)
Phase 2 Active not recruiting